Inflection Biosciences recognises the importance of effective strategic partnering across the drug development process in the successful achievement of its business objectives. Partnering is central to the key activities of the company, with research and academic alliance partners providing Inflection Biosciences with access to promising cancer discoveries, contract research organisations underpinning its capital efficient drug development objectives and large pharmaceutical company partners playing a prominent role in the execution of the later stage clinical development phases followed by launch of products in the market place. 


Search - Use spaces to separate your keywords
Inflection Biosciences. Suite 15, Anglesea House Carysfort Avenue, Blackrock,  Co. Dublin.  

 Company registration no. 509046.

© 2018 Inflection Biosciences.   Web Design by Webtrade